ASHOK VARMA

Employment

• Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) faculty

Education

• Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) PhD

Projects & Funding

Projects & funding information is unavailable.

Publications (8)

• Evaluation of Pathogenicity and Structural Alterations for the Mutations Identified in the Conserved Region of the C-Terminal Kinase Domain of Human-Ribosomal S6 Kinase 1
  ACS Omega 2023 DOI: 10.1021/acsomega.3c00722
  +Save
• In Silico-Based Structural Evaluation to Categorize the Pathogenicity of Mutations Identified in the RAD Class of Proteins
  ACS Omega 2023 DOI: 10.1021/acsomega.2c07802
  +Save
• In silico structural analysis of secretory clusterin to assess pathogenicity of mutations identified in the evolutionarily conserved regions
  Journal of Biomolecular Structure and Dynamics 2023 DOI: 10.1080/07391102.2021.2007791
  +Save
• In Silico and Structure-Based Assessment of Similar Variants Discovered in Tandem Repeats of BRCT Domains of BRCA1 and BARD1 To Characterize the Folding Pattern
  ACS Omega 2022 DOI: 10.1021/acsomega.2c04782
  +Save
• Crystal structure of clinically reported mutations Gly656Arg, Gly656Glu and Asp751His identified in the kinase domain of EphA7
  Biochemical and Biophysical Research Communications 2021 DOI: 10.1016/j.bbrc.2021.06.048
  +Save
• Quantitative Serum Proteomics Reveals The Predictive and Prognostic Potential of Clusterin and Gelsolin in Head and Neck Squamous Cell Carcinoma Treated With Radiotherapy
  2021 DOI: 10.21203/rs.3.rs-827705/v1
  +Save
• Comprehensive Analysis of Low Molecular Weight Serum Proteome Enrichment for Mass Spectrometric Studies
  ACS Omega 2020 DOI: 10.1021/acsomega.0c04568
  +Save
• Biophysical evaluation to categorize pathogenicity of cancer-predisposing mutations identified in the BARD1 BRCT domain
  RSC Advances 2018 DOI: 10.1039/C8RA06524A
  +Save